Mechanism studies suggest that the tumor-suppressive effect of miR-23a-3p may inhibit the malignant progression of oral squamous cell carcinoma by inhibiting the Runx2 regulation of PTEN/PI3K/Akt signaling pathway. This evidence concerns the gene AKT1 and neoplasm.